We are live on ! Find out more
MBIO icon

Mustang Bio

67 hedge funds and large institutions have $6.8M invested in Mustang Bio in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 24 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.02%0.02% (-0%)

6% less funds holding

Funds holding: 7167 (-4)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

34% less capital invested

Capital invested by funds: $10.3M → $6.8M (-$3.52M)

58% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 24

Holders
67
Holders Change
-4
Holders Change %
-5.63%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
10
Reduced
24
Closed
12
Calls
$29K
Puts
Net Calls
+$29K
Net Calls Change
-$32K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$35K
Barclays
27
Barclays
United Kingdom
$30K -$3.24K -7 -8%
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$25K -$1.39K -3 -4%
CAN
29
Cetera Advisor Networks
California
$25K
DC
30
Davenport & Co
Virginia
$17K
LP
31
LMR Partners
United Kingdom
$17K
Charles Schwab
32
Charles Schwab
California
$15K
EL
33
EMFO LLC
Florida
$15K
Commonwealth Equity Services
34
Commonwealth Equity Services
Massachusetts
$15K +$8.34K +18 +69%
Balyasny Asset Management
35
Balyasny Asset Management
Illinois
$15K +$11.1K +24 +133%
Baird Financial Group
36
Baird Financial Group
Wisconsin
$15K +$19.9K +43 New
JP Morgan Chase
37
JP Morgan Chase
New York
$12K -$941K -2,031 -98%
FLPIM
38
F.L. Putnam Investment Management
Massachusetts
$12K
FAIM
39
Financial Advocates Investment Management
Washington
$11K -$10.2K -22 -45%
TRCT
40
Tower Research Capital (TRC)
New York
$10K +$3.24K +7 +33%
Envestnet Asset Management
41
Envestnet Asset Management
Illinois
$9K -$41.2K -89 -77%
LWAM
42
Legacy Wealth Asset Management
Minnesota
$9K
SCA
43
Sassicaia Capital Advisers
New York
$9K +$1.39K +3 +14%
Creative Planning
44
Creative Planning
Kansas
$9K +$12.5K +27 New
Ameriprise
45
Ameriprise
Minnesota
$8K -$18.5K -40 -65%
SSA
46
Schonfeld Strategic Advisors
New York
$8K +$10.7K +23 New
AWM
47
Apollon Wealth Management
South Carolina
$7K
Group One Trading
48
Group One Trading
Illinois
$7K
AWA
49
Arete Wealth Advisors
Illinois
$7K +$9.73K +21 New
BC
50
Burney Company
Virginia
$5K

MBIO Hedge Fund Activity: Q3 2022 in Review

67 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q3 2022, worth a combined $6.8M — down 34% from $10.3M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of MBIO and 9 opened new positions — a net loss of 3 holders — while 24 trimmed existing stakes and 10 added.

The largest buyer was Vanguard Group, adding an estimated $298K. The largest seller was JP Morgan Chase, cutting an estimated $941K.

  • 67 institutional investors held Mustang Bio (MBIO) as of Q3 2022, down from 71 in Q2 2022.
  • Funds reported $6.8M of Mustang Bio stock for Q3 2022, down 34% quarter-over-quarter.
  • 9 funds opened new Mustang Bio positions in Q3 2022 and 12 closed out, a net change of -3 holders.
  • The largest Mustang Bio buyer in Q3 2022 was Vanguard Group, an estimated $298K added.
  • The largest Mustang Bio seller in Q3 2022 was JP Morgan Chase, an estimated $941K sold.

Based on aggregated 13F filings for Q3 2022.